Am J Clin Nutr 2000 Aug;72(2 Suppl):618S-23S Volek JS, Kraemer WJ, Rubin MR, Gomez AL, Ratamess NA, Gaynor P
Tirzepatide (Mounjaro/Zepbound) Potential: Newer research reviews (2025) have highlighted Tirzepatidewhich targets both GLP-1 and GIP receptorsas a potential "disease-modifying" therapy
Addressable Market Size and Barriers to Uptake GLP-1 receptor agonist drugs are likely to completely reshape the global sugar market
Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
Exosomes are tiny extracellular vesicles, measuring 30-150 nanometers in diameter, that are naturally released by all cells in the body
However, lower doses can still result in weight loss, though less dramatic